BioCentury
ARTICLE | Clinical News

Alethia preclinical data

December 14, 2009 8:00 AM UTC

In a mouse model of metastatic cancer, AB-16B5 plus Taxotere docetaxel increased tumor growth inhibition by 40-60% vs. chemotherapy alone. In a mouse model of breast carcinoma, AB-16B5 reduced metast...